Phibro Animal Health PAHC
NASDAQ PAHC
$37.24 +1.37 (+3.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Phibro Animal Health (PAHC) Selling, General & Administrative (2012 - 2026)

Updated

Phibro Animal Health (PAHC) posted Selling, General & Administrative of $86.24 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 13.0% from $76.29 million a year earlier and up 6.4% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Selling, General & Administrative (2012 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Phibro Animal Health's Selling, General & Administrative came in at $318.12 million, up 9.9% from FY2025.

  • Annual Selling, General & Administrative has increased for nine consecutive fiscal years, with a five-year compound annual growth rate of 10.1% (FY2021 to FY2026).
  • In prior fiscal years, Phibro Animal Health's Selling, General & Administrative was $289.48 million in FY2025 (+11.4%), $259.78 million in FY2024 (+14.7%), $226.39 million in FY2023 (+9.7%) and $206.41 million in FY2022 (+5.0%).
  • The fiscal Q4 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to fiscal Q1 2013.
  • On a year-over-year basis, Selling, General & Administrative has increased in each of the last seven quarters, with growth averaging 10.8% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was fiscal Q4 2024, with growth of 29.9%; the weakest was fiscal Q4 2023, with a decline of 4.7%.
  • According to Business Quant data, Selling, General & Administrative for the three prior fiscal quarters was $81.02 million (Q3 2026), $82.33 million (Q2 2026) and $68.52 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Phibro Animal Health 1.51 Bn 1.19 Bn 134.40 Mn 86.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 86.24 Mn
Mar 31, 2026 81.02 Mn
Dec 31, 2025 82.33 Mn
Sep 30, 2025 68.52 Mn
Jun 30, 2025 76.29 Mn
Mar 31, 2025 71.05 Mn
Dec 31, 2024 76.34 Mn
Sep 30, 2024 65.80 Mn
Jun 30, 2024 68.73 Mn
Mar 31, 2024 59.68 Mn
Dec 31, 2023 62.92 Mn
Sep 30, 2023 68.45 Mn
Jun 30, 2023 52.90 Mn
Mar 31, 2023 56.99 Mn
Dec 31, 2022 61.54 Mn
Sep 30, 2022 54.96 Mn
Jun 30, 2022 55.54 Mn
Mar 31, 2022 52.43 Mn
Dec 31, 2021 48.38 Mn
Sep 30, 2021 50.07 Mn
API Access

Phibro Animal Health Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PAHC&period=max&api_key=YOUR_API_KEY